Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018

• by Laura M King, Katia J Bruxvoort, Sara Y Tartof, Joseph A Lewnard

• June 7, 2025

Correction: Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1

• by Ines Zettl, Isabella Ellinger, Mohammed Zghaebi, Sarah Jance, Vanessa Izewski, Anja Drescher, Heimo Breiteneder, Manuel Röck, Martin Tollinger, Julia Eckl-Dorna, Sergei V. Tillib, Sabine Flicker

• September 11, 2026

Prediction models for sepsis-associated acute kidney injury: a systematic review and meta-analysis

• by Muze Huang, Shiyuan Wu, Zi-Han Shen, Sarena Jiayao Zhang, Yaw-syan Fu, Jingyi Wu

• September 14, 2026

Musings from The Power List: Ali Tavassoli

Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology

• by Ali Tavassoli

• September 10, 2026

• 9 min